Global Gastrointestinal Diseases Therapeutics Market (2020 to 2024) - Featuring Abbott, AbbVie & AstraZeneca Among Others - ResearchAndMarkets.com

DUBLIN--()--The "Global Gastrointestinal Diseases Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

The gastrointestinal diseases therapeutics market is poised to grow by $ 22.82 bn during 2020-2024 progressing at a CAGR of 9% during the forecast period. The reports on gastrointestinal diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of gastrointestinal diseases, new product launches, and demand for biologics and targeted therapies. In addition, increasing incidence of gastrointestinal diseases is anticipated to boost the growth of the market as well.

The gastrointestinal diseases therapeutics market analysis includes drug class segment and geographic landscapes.

This study identifies the strong product pipeline as one of the prime reasons driving the gastrointestinal diseases therapeutics market growth during the next few years. Also, funding for gastrointestinal research studies, and increase in self-medication coupled with home-based therapies will lead to sizable demand in the market.

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Co. Ltd.
  • UCB SA

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by Drug class

  • Market segments
  • Comparison by Drug class
  • Anti-inflammatory and immunosuppressors - Market size and forecast 2019-2024
  • Acid neutralizers - Market size and forecast 2019-2024
  • Other therapeutics - Market size and forecast 2019-2024
  • Market opportunity by Drug class

6. Customer landscape

7. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Market challenges
  • Market trends

8. Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption
  • Industry risks

9. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors

10. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/f77flu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900